Providing Sitting Balance Training With a Newly Developed Rehabilitation Device
T-Chair
Monocenter Interventional Study: Providing Sitting Balance Training With a Newly Developed Rehabilitation Device in the Chronic Stage After Stroke A Feasibility and Pilot Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
This clinical study is being conducted to evaluate a new training device, the T-CHAIR, for trunk rehabilitation and post-stroke balance. The investigators would like to study three objectives. First, the investigators want to examine whether training with a new training device is feasible and safe during rehabilitation in the later phase, more than six months after a stroke. The investigators also evaluate whether training with a new training device has an effect on the sitting balance and the function and strength of the trunk. Finally, the investigators examine whether training with a new training device has an effect on walking, standing and activities of daily life and self-care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2020
CompletedFirst Posted
Study publicly available on registry
July 13, 2020
CompletedStudy Start
First participant enrolled
July 17, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 13, 2021
CompletedJanuary 28, 2022
January 1, 2022
5 months
June 29, 2020
January 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Recruitment
Recruitment is characterized by the number of possible participants divided by the number of participants actually participated in the trial.
Through study completion, an average of 1.5 months.
Retention
Retention is the number of participants that complete the whole trial divided by the number of participants that are included in the study.
Through study completion, an average of 1.5 months.
Participation
During each therapy the therapist evaluates the participation of each candidate.
Through study completion, an average of 1.5 months.
Adherence
After each therapy session the therapist evaluates the adherence using the Clinician Rating of Compliance Scale. This is a seven point ordinal scale which assesses the level of adherence of the patient. A higher score represent better adherence. A score lower than five is defined as non-adherent.
Through study completion, an average of 1.5 months.
Acceptability and enjoyment
The level of enjoyment during the training will be assessed using the physical activity enjoyment scale. This scale contains 18 items, during the training participants have to score how they feel about the training on a seven-point bipolar scale. The lowest score stands for less enjoyment or acceptance, a higher score stands for maximum enjoyment or acceptance.
Through study completion, an average of 1.5 months.
Safety and Adverse events
Safety is evaluated by retaining all adverse events during the therapy sessions.
Through study completion, an average of 1.5 months.
Device development or modifications
Feedback from the participants and therapists to improve the device are noted after every session. Each patient and therapist who came in contact with the device received an experience questionnaire. The questionnaire contains 16 questions, 3 questions and 13 categorical questions on 5 or 7 point Likert scale.
Through study completion, an average of 1.5 months.
Fatigue
After each training session fatigue will be evaluated using Visual Analog Fatigue Scale.This scale consists of a 10 cm horizontal line with written description at each end of the line. The written description varies from no fatigue to Very Severe Fatigue on top of the 10 cm line.
Through study completion, an average of 1.5 months.
Patient Global Impression of Change
The patient Global impression of change is a one single question to rate their condition after the therapy sessions compared to the rate of their condition at the start of the therapy session. This scale will be evaluated twice. One time after two weeks of intervention and once after the four weeks of intervention.
Through study completion, an average of 1.5 months.
Secondary Outcomes (11)
Trunk function
Through study completion, an average of 1.5 months.
Trunk stability
Through study completion, an average of 1.5 months.
Trunk strength
Through study completion, an average of 1.5 months.
Sitting balance
Through study completion, an average of 1.5 months.
Walking speed
Through study completion, an average of 1.5 months.
- +6 more secondary outcomes
Study Arms (2)
Measurements and T-chair training
EXPERIMENTALThis group will receive three measurements sessions and training with a new developed device (15 therapy sessions in total).
Measurements
NO INTERVENTIONThis group will receive three measurements sessions.
Interventions
Participants will receive 15 sessions of intervention, four weeks in total with a duration of one hour for each session. The focus of the intervention will be trunk rehabilitation.
Eligibility Criteria
You may qualify if:
- First major stroke event, a transient ischemic attack or a previous stroke with full recovery is allowed.
- Impairment of the trunk function, with a maximum score of 19 on the trunk impairment scale .
- Able to maintain seated position for more than 10 seconds.
- Able to come to the rehabilitation ward as a chronic patient.
- More than six months after a stroke event.
- Older than 18 years.
- With no comorbidities other than stroke affecting trunk function. Comorbidities could be musculoskeletal problems or other neurological diseases.
- With sufficient cognitive and language capacity to perform the assessment.
You may not qualify if:
- Not able to give informed consent.
- Not approved informed consent.
- Subject does not understand the study procedures.
- Subject has any history of another major neurological disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
Liselot Thijs
Leuven, 3000, Belgium
Related Publications (1)
Thijs L, Voets E, Wiskerke E, Nauwelaerts T, Arys Y, Haspeslagh H, Kool J, Bischof P, Bauer C, Lemmens R, Baumgartner D, Verheyden G. Technology-supported sitting balance therapy versus usual care in the chronic stage after stroke: a pilot randomized controlled trial. J Neuroeng Rehabil. 2021 Jul 28;18(1):120. doi: 10.1186/s12984-021-00910-7.
PMID: 34321042DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 29, 2020
First Posted
July 13, 2020
Study Start
July 17, 2020
Primary Completion
December 18, 2020
Study Completion
July 13, 2021
Last Updated
January 28, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share